NCT06771128View on ClinicalTrials.gov

Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis

NAActive, not recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

October 1, 2025

Conditions
Nocturnal Enuresis in ChildrenDesmopressinMonosymptomatic Nocturnal Enuresis
Interventions
DRUG

Ginkgo Biloba oral tablet

patients receive Ginkgo Biloba oral tablet 120 mg once daily

DRUG

Desmopressin Acetate 0.2 mg Tablets

patient receives desmopressin 0.2 mg oral tablet once daily

DRUG

Placebo

patients receive Placebo oral tablet once daily

Trial Locations (1)

32511

Menoufia Faculty of Medicine, Shebin El-Kom

All Listed Sponsors
lead

Menoufia University

OTHER

NCT06771128 - Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis | Biotech Hunter | Biotech Hunter